The latest announcement is out from Zentalis Pharmaceuticals (ZNTL).
Starting June 3, 2024, Zentalis Pharmaceuticals, Inc. representatives will share insights from their Corporate Presentation with investors and analysts at various conferences and meetings. The information shared, while important, isn’t considered legally “filed” under the Securities Exchange Act, nor is it linked to any associated liabilities, and it won’t be included in future filings unless specifically referenced.
Find detailed analytics on ZNTL stock on TipRanks’ Stock Analysis page.
